Compositions and methods in cancer associated with altered expression of PRLR
US7645441B2 · kind B2 · utility
0Cited by
43References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 2002 |
| Grant date | Jan 12, 2010 |
| Priority date | — |
| Expiry date | Sep 8, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/25
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially breast cancers. In addition, the present invention describes the use of novel compositions for use in screening methods. The invention provides compositions and methods associated with altered expression of PRLR in cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.